<DOC>
	<DOCNO>NCT00002639</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness suramin treat patient recurrent primary brain tumor follow radiation therapy .</brief_summary>
	<brief_title>Suramin Treating Patients With Recurrent Primary Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate efficacy suramin patient recurrent primary brain tumor measure radiographic response , time progression , survival . II . Assess toxic effect suramin patient population . OUTLINE : Single-Agent Chemotherapy . Suramin , SUR , NSC-34936 . PROJECTED ACCRUAL : If least 1 first 14 patient experience least partial response , total 25 patient enter approximately 30 month .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Suramin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Recurrent brain tumor base one following : Tissue diagnosis prior diagnosis astrocytoma oligodendroglioma question radiation necrosis prior interstitial brachytherapy Metabolic activity excess normal cortex measure 18fluorodeoxyglucose uptake PET One follow histologic type require : Glioblastoma multiforme Anaplastic astrocytoma Anaplastic oligodendroglioma Anaplastic mixed glioma Tumor progression require , i.e . : 28 % increase contrastenhancing area 50 % increase contrast enhancing volume least 4 week Measurable disease require No history , surgical finding , radiographic sign intratumoral hemorrhage PATIENT CHARACTERISTICS : Age : Over 15 Performance status : Karnofsky 50 % 100 % Life expectancy : At least 12 week Hematopoietic : WBC least 3,000 Platelets least 75,000 Hepatic : Bilirubin le 1.5 mg/dL AST/ALT le 3 time normal No history bleed disorder No hepatic disease result hospitalization Renal : Creatinine le 1.5 mg/dL No renal disease result hospitalization Cardiovascular : No ongoing anticoagulation deep vein thrombosis ( DVT ) No residual symptom DVT discontinuation anticoagulation No cardiac disease result hospitalization Pulmonary : No pulmonary disease result hospitalization Other : No peripheral neuropathy etiology HIV negative No pregnant nursing woman Adequate contraception require 12 month follow protocol therapy PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy glioblastoma multiforme No 1 prior chemotherapy regimen anaplastic astrocytoma , malignant oligodendroglioma , malignant mixed glioma At least 4 week since chemotherapy ( 6 week since nitrosoureas mitomycin ) Endocrine therapy : Not specify Radiotherapy : Completion 1 course conventional external radiotherapy require At least 4 week since radiotherapy Surgery : Decompressive surgery clinically suspect increased intracranial pressure perform prior entry</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2001</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>